<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02135705</url>
  </required_header>
  <id_info>
    <org_study_id>AEGR-733-025</org_study_id>
    <nct_id>NCT02135705</nct_id>
  </id_info>
  <brief_title>LOWER: Lomitapide Observational Worldwide Evaluation Registry</brief_title>
  <acronym>LOWER</acronym>
  <official_title>LOWER: Lomitapide Observational Worldwide Evaluation Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Amryt Pharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Amryt Pharma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This global product exposure registry is a multicentre, long-term, prospective, observational&#xD;
      cohort study (exposure registry), designed to evaluate the long term safety and effectiveness&#xD;
      of lomitapide.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the occurrence of adverse events of special interest, long term effectiveness of&#xD;
      lomitapide, and to evaluate whether prescribers of lomitapide are following screening and&#xD;
      monitoring recommendations as specified in product labeling.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 18, 2014</start_date>
  <completion_date type="Anticipated">September 1, 2028</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2028</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Hepatic Abnormalities</measure>
    <time_frame>patients will be followed for 10 years</time_frame>
    <description>to evaluate the occurrence of hepatic abnormalities</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gastrointestinal (GI) Events</measure>
    <time_frame>patients will be followed for 10 years</time_frame>
    <description>to evaluate the occurrence of GI events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tumors</measure>
    <time_frame>patients will be followed for 10 years</time_frame>
    <description>to evaluate any occurrence of tumors (small bowel, hepatic, colorectal or pancreatic)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Events associated with coagulopathy</measure>
    <time_frame>patients will be followed for 10 years</time_frame>
    <description>to evaluate the occurrence of events associated with coagulopathy (abnormal bleeding, cerebral haemorrhage or GI bleeding)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiovascular Events (MACE) events</measure>
    <time_frame>patients will be followed for 10 years</time_frame>
    <description>to evaluate the occurrence of MACE events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death, including cause of death</measure>
    <time_frame>patients will be followed for 10 years</time_frame>
    <description>to evaluate the occurrence and cause of death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pregnancy</measure>
    <time_frame>patients will be followed for 10 years</time_frame>
    <description>to evaluate the occurrence and outcomes of pregnancy in females of reproductive potential treated with lomitapide. Patients who become pregnant will be offered enrolment into a separate Pregnancy Exposure Registry (PER).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Serum lipid levels</measure>
    <time_frame>patients will be followed for 10 years</time_frame>
    <description>to evaluate the long-term effectiveness of lomitapide in maintaining control of serum lipid levels in a clinical practice setting.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prescriber behavior</measure>
    <time_frame>patients will be followed for 10 years</time_frame>
    <description>to evaluate whether prescribers of lomitapide enrolled at registry sites are following the screening and monitoring recommendations as specified in the PI and the prescriber educational materials aimed at risk minimization.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Homozygous Familial Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>Lomitapide</arm_group_label>
    <description>Lomitapide as prescribed by Physician.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lomitapide</intervention_name>
    <description>As prescribed by Physician.</description>
    <arm_group_label>Lomitapide</arm_group_label>
    <other_name>Juxtapid</other_name>
    <other_name>Lojuxta</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients treated with lomitapide who agree to participate in the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients (age â‰¥18 years) who meet one of the following two criteria:&#xD;
&#xD;
        Initiating treatment with lomitapide at the time of registry enrolment, or initiated&#xD;
        treatment with lomitapide within 36 months prior to enrolment into the registry and after&#xD;
        lomitapide commercial availability in the country.&#xD;
&#xD;
          -  Patients who have the ability to understand the requirements of the study and provide&#xD;
             written informed consent to comply with the study data collection procedures.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who are receiving lomitapide in clinical trials or through compassionate use&#xD;
             where patients are followed under a separate protocol&#xD;
&#xD;
          -  Patients receiving an investigational agent, defined as any drug or biologic agent&#xD;
             other than lomitapide that has not received MA in the country of participation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sallyann O'Brien</last_name>
    <role>Study Director</role>
    <affiliation>Amryt Pharmaceuticals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sallyann O'Brien</last_name>
    <phone>1 855 303 2347</phone>
    <email>medinfo@amrytpharma.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Brookwood Baptist Medical Center</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barry McLean, MD</last_name>
      <phone>205-949-1907</phone>
      <email>bmclean@centralalabamaresearch.com</email>
    </contact>
    <investigator>
      <last_name>Barry McLean, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Springhill Physician Practices</name>
      <address>
        <city>Mobile</city>
        <state>Alabama</state>
        <zip>36608</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Northern Arizona Healthcare</name>
      <address>
        <city>Cottonwood</city>
        <state>Arizona</state>
        <zip>86326</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samuel Butman, MD</last_name>
      <phone>928-634-1331</phone>
      <email>sbutman@aol.com</email>
    </contact>
    <investigator>
      <last_name>Samuel Butman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>One Medical</name>
      <address>
        <city>Gilbert</city>
        <state>Arizona</state>
        <zip>85296</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Scottsdale Family Health</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85018</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joseph Lillo, DO</last_name>
      <phone>480-941-4845</phone>
      <email>jlillo3@cox.net</email>
    </contact>
    <investigator>
      <last_name>Joseph Lillo, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pima Heart</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85718</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Arkansas Heart Center</name>
      <address>
        <city>Fort Smith</city>
        <state>Arkansas</state>
        <zip>72901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prediman Shah, MD</last_name>
      <phone>310-967-1884</phone>
      <email>prediman.shah@cshs.org</email>
    </contact>
    <investigator>
      <last_name>Prediman Shah, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado Health</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marybeth Allian-Sauer, MD</last_name>
      <phone>720-848-6515</phone>
      <email>marybeth.allian-sauer@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>Marybeth Allian-Sauer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alfieri Cardiology</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anthony Alfieri, MD</last_name>
      <phone>302-691-3118</phone>
      <email>aalfieriresearch@aol.com</email>
    </contact>
    <investigator>
      <last_name>Anthony Alfieri, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Preventative Cardiology, Inc.</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33434</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seth Baum, MD</last_name>
      <phone>561-488-5535</phone>
      <email>sjbaum@fpim.org</email>
    </contact>
    <investigator>
      <last_name>Seth Baum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Lipid Institute</name>
      <address>
        <city>Winter Park</city>
        <state>Florida</state>
        <zip>32792-2223</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Piedmont Heart Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janice McAlister, NP</last_name>
      <phone>404-605-2800</phone>
      <email>jan.mcalister@piedmont.org</email>
    </contact>
    <investigator>
      <last_name>Janice McAlister, NP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atlanta Heart Specialists</name>
      <address>
        <city>Cumming</city>
        <state>Georgia</state>
        <zip>30041</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Narendra Singh, MD</last_name>
      <phone>404-384-7227</phone>
      <email>mnsingh@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Narendra Singh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Comprehensive Cardiovascular Care</name>
      <address>
        <city>Gurnee</city>
        <state>Illinois</state>
        <zip>60031</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isaac Dor, MD</last_name>
      <phone>224-656-5867</phone>
      <email>idor@c3gurnee.com</email>
    </contact>
    <investigator>
      <last_name>Isaac Dor, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Community Health Network</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46250</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>St. Vincent Medical Group, Inc.</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46290</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Trippi, MD</last_name>
      <phone>317-924-5444</phone>
      <email>jatrippi@stvincent.org</email>
    </contact>
    <investigator>
      <last_name>James Trippi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henry County Medical Center</name>
      <address>
        <city>New Castle</city>
        <state>Kentucky</state>
        <zip>40050</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Institute of the South</name>
      <address>
        <city>Houma</city>
        <state>Louisiana</state>
        <zip>70360</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Fail, MD</last_name>
      <phone>985-876-0300</phone>
      <email>peter.fail@cardio.com</email>
    </contact>
    <investigator>
      <last_name>Peter Fail, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Get Well Immediate Care</name>
      <address>
        <city>Towson</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>University of Michigan Health System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Complete Family Care Cholesterol Treatment Center</name>
      <address>
        <city>Sterling Heights</city>
        <state>Michigan</state>
        <zip>48314</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Enrolling by invitation</status>
  </location>
  <location>
    <facility>
      <name>Minneapolis Heart Institute Foundation</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Knickelbine, MD</last_name>
      <phone>612-863-4071</phone>
      <email>thomas.knickelbine@allina.com</email>
    </contact>
    <investigator>
      <last_name>Thomas Knickelbine, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HealthEast Care System</name>
      <address>
        <city>Saint Paul</city>
        <state>Minnesota</state>
        <zip>55102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leslie Forgosh, MD</last_name>
      <phone>651-232-4340</phone>
      <email>lforgosh@healtheast.org</email>
    </contact>
    <investigator>
      <last_name>Leslie Forgosh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stern Cardiovascular Foundation</name>
      <address>
        <city>Southaven</city>
        <state>Mississippi</state>
        <zip>38671</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dharmesh Patel, MD</last_name>
      <phone>901-271-5468</phone>
      <email>drdharmesh@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Dharmesh Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Methodist Physicians Clinic</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Henry, MD</last_name>
    </contact>
    <contact_backup>
      <phone>(402) 384-2705</phone>
      <email>john.henry@nmhs.org</email>
    </contact_backup>
    <investigator>
      <last_name>John Henry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hackensack Meridian Health</name>
      <address>
        <city>Edison</city>
        <state>New Jersey</state>
        <zip>08817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Avinash C. Gupta, MD, PC</name>
      <address>
        <city>Lakewood</city>
        <state>New Jersey</state>
        <zip>08701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>201 Route 17 North</name>
      <address>
        <city>Rutherford</city>
        <state>New Jersey</state>
        <zip>07070</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Schwarz, MD</last_name>
      <phone>732-713-2872</phone>
      <email>dar.schwarz201@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Michael Schwarz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Valley Medical Group</name>
      <address>
        <city>Wyckoff</city>
        <state>New Jersey</state>
        <zip>07481</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Howard Frauwirth, MD</last_name>
      <phone>201-891-5044</phone>
      <email>frauho@valleyhealth.com</email>
    </contact>
    <investigator>
      <last_name>Howard Frauwirth, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Murray Hill Medical Group</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Underberg, MD</last_name>
      <phone>212-726-7431</phone>
      <email>james.underberg@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>James Underberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NY Heart Center</name>
      <address>
        <city>Syracuse</city>
        <state>New York</state>
        <zip>13210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Micheal Gabris, MD</last_name>
      <phone>315-671-1482</phone>
      <email>mgabris@ny-heartcenter.com</email>
    </contact>
    <investigator>
      <last_name>Micheal Gabris, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiology Specialists Of Carolina</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Wise, MD</last_name>
      <phone>704-369-8080</phone>
      <email>toowiseguys@me.com</email>
    </contact>
    <investigator>
      <last_name>Daniel Wise, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Heart Care Group, PC</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>St. Luke's University Health Network - Pennsylvania</name>
      <address>
        <city>Bethlehem</city>
        <state>Pennsylvania</state>
        <zip>18015</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Hospital And Health Network</name>
      <address>
        <city>East Stroudsburg</city>
        <state>Pennsylvania</state>
        <zip>18301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Cardiology Consultants of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University Health System</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19148</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Whellan, MD</last_name>
      <phone>215-503-4282</phone>
      <email>Melissa.McCarey@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>David Whellan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Palmetto Health</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vince Vismara, MD</last_name>
      <phone>803-739-6500</phone>
      <email>vince.vismara@palmettohealth.org</email>
    </contact>
    <investigator>
      <last_name>Vince Vismara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>317 Saint Francis Dr.</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Siegel, MD</last_name>
      <phone>864-232-8296</phone>
      <email>siegeljsjsjs@aol.com</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Siegel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Specialists of Texas</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78758</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Baylor Scott &amp; White Health</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter McCullough, MD</last_name>
      <phone>214-820-7997</phone>
      <email>peter.mccullough@bswhealth.org</email>
    </contact>
    <investigator>
      <last_name>Peter McCullough, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Vermont Health Network</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401-1473</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Schneider, MD</last_name>
      <phone>802-847-3734</phone>
      <email>david.schneider@uvm.edu</email>
    </contact>
    <investigator>
      <last_name>David Schneider, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West Virginia University Medicine</name>
      <address>
        <city>Morgantown</city>
        <state>West Virginia</state>
        <zip>26506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anthony Morise, MD</last_name>
      <phone>304-598-4651</phone>
      <email>tmorise@hsc.wvu.edu</email>
    </contact>
    <investigator>
      <last_name>Anthony Morise, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ascension</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Terminated</status>
  </location>
  <location>
    <facility>
      <name>Aspirus Research Institute</name>
      <address>
        <city>Wausau</city>
        <state>Wisconsin</state>
        <zip>54401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Murdock, MD</last_name>
      <phone>715-847-2611</phone>
      <email>dkmurdock@charter.net</email>
    </contact>
    <investigator>
      <last_name>David Murdock, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>April 10, 2014</study_first_submitted>
  <study_first_submitted_qc>May 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2014</study_first_posted>
  <last_update_submitted>December 2, 2020</last_update_submitted>
  <last_update_submitted_qc>December 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperlipoproteinemia Type II</mesh_term>
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

